Pharmafile Logo
Pharmafocus logo
Advanced Search

Press release

Showing 15 posts of 581 posts found.

PHARMANOVIA EXPANDS EXCLUSIVE LICENSING COLLABORATION WITH AQUESTIVE THERAPEUTICS FOR DIAZEPAM BUCCAL FILM

March 30, 2023
Business Services

Basildon, UK – For immediate release, 27 March 2023   Pharmanovia, a global pharmaceutical company that revitalises, extends and expands …

News
Press release

Unite Health: Thousands Honor Pandemic ‘Influencers’ Through COVID-19 Social Media Awards

March 30, 2023
Business Services

  London, UK | In a global display of appreciation, thousands of people are recognizing social media influencers who used …

News
Press release

Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B

March 28, 2023
Business Services

OXFORD, United Kingdom, March 28, 2023 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company focused on the …

News
Press release

Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry

March 28, 2023
Business Services

Milan, Italy, March 28, 2023, 12:30 pm CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company …

News
Press release

TEZSPIRE▼(TEZEPELUMAB) TO BE RECOMMENDED BY NICE AS AN ADD-ON TREATMENT FOR SEVERE UNCONTROLLED ASTHMA

March 28, 2023
Business Services

London, UK, Tuesday 28 March 2023 – AstraZeneca today announced that the National Institute for Health and Care Excellence (NICE) …

News
Press release

Tavneos® (avacopan) included in updated EULAR recommendations for the management of AAV

March 28, 2023
Business Services

ST. GALLEN, Switzerland, March 28, 2023 /PRNewswire/ — Vifor Fresenius Medical Care Renal Pharma (VFMCRP) is pleased to announce that …

News
Press release

iOnctura awarded UK’s MHRA Innovation Passport for entry into innovative licensing and access pathway (ILAP)

March 28, 2023
Business Services

Geneva, Switzerland and Amsterdam, The Netherlands, 28 March – iOnctura, a clinical stage biotechnology company developing breakthrough therapies for patients …

News
Press release

Sofinnova Partners launches Digital Medicine Strategy

March 28, 2023
Business Services

PARIS, France – March 28, 2023 – Sofinnova Partners (“Sofinnova”), a leading European life sciences venture capital firm based in …

News
Press release

Vantage Nutrition LLC acquires ComboCap Inc

March 28, 2023
Business Services

Vantage Nutrition, an ACG group company announces full shareholding ownership of ComboCap Inc (USA) and BioCap (South Africa).  

News
Press release

Particle Works partners with Earli Inc. to develop DNA-LNPs for early-stage cancer treatment

March 27, 2023
Business Services

Particle Works, a leading provider of innovative microfluidic nanoparticle synthesis platforms, is supporting Earli Inc. in its mission to detect, …

News
Press release

Revolo Biotherapeutics Announces Completion of Phase 2a Trial of ‘1104 in Allergic Disease

March 27, 2023
Business Services

NEW ORLEANS, LA and CAMBRIDGE, England, March 27, 2023 – Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a company developing …

News
Press release

Statement Following Jounce Therapeutics Announcement of a Definitive Merger Agreement with Concentra Biosciences and Withdrawal of their Recommendation for the Business Combination with Redx

March 27, 2023
Business Services

Alderley Park, UK 27 March 2023 Redx Pharma (“Redx”, AIM: REDX), the clinical-stage biotechnology company focused on discovering and developing …

News
Press release

MHRA Grants Conditional Marketing Authorisation in Great Britain to CSL’s HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Haemophilia B

March 27, 2023
Business Services

This medicine is subject to additional monitoring.This will allow quick identification of new safety information.

News
Press release

Avacta to present pre-clinical data on AVA3996 at the American Association for Cancer Research Annual Meeting

March 27, 2023
Business Services

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, announces it will …

News
Press release

Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS

March 27, 2023
Business Services

Leiden, The Netherlands, March 24, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025